Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancerNa Zhao, Jeffrey M. Rosen, Diego A. Pedroza et al.|Journal of Clinical Investigation|2023Cited by 29
CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancerXueying Yuan, Jeffrey M. Rosen|JCI Insight|2024Cited by 14
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancerNa Zhao, Jeffrey M. Rosen, Elena B. Kabotyanski et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBCXueying Yuan, Jeffrey M. Rosen|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0